Заказ звонка
* Представьтесь:
* Ваш телефон:
Сообщение:
* - поля, обязательные для заполнения
Заказать звонок
info@logospress.ru
+7 (495) 689-85-16
+7 (495) 220-48-16

Список литературы

А.Е. Богорад, П.П. Захаров, Н.Н. Розинова, Ю.Л. Мизерницкий.
Синдром Гудпасчера. Клиническое наблюдение



  1. Miklovicova D., Cornelissen M., Cransberg K., Groothoff J.W., Dedik L., Schroder C.H. Etiology and epidemiology of end-stage renal disease in Dutch children 1987-2001 // Pediatr Nephrol. Aug 2005; 20(8): 1136–42.

  2. Bigler S.A., Parry W.M., Fitzwater D.S., Baliga R. An 11-month-old with anti-glomerular basement membrane disease // Am J Kidney Dis. Nov 1997;30(5): 710–2.

  3. United States Renal Data System (USRDS). 2008 Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. http://www.usrds.org/adr.htm.

  4. OMIM (Online Mendelian Inheritance in Man) http://www.ncbi.nlm.nih.gov/omim.

  5. http://www.orpha.net/consor/cgi-bin.

  6. Розинова Н.Н., Лев Н.С., Богорад А.Е. Эпонимические синдромы в пульмонологии. Справочник. – М.: Практика, 2011. – 87c.

  7. Goodpasture E.W. The significance of certain pulmonary lesions in relation to the etiology of influenza // Am J Med Sci 1919;158 (6): 863–870.

  8. Lerner R.A., Glassock R.J., Dixon F.J. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis // J Exp Med. Dec 1 1967;126(6):989–1004.

  9. Turner N., Mason P.J., Brown R., Fox M., Povey S., Rees A., Pusey C.D. Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha-3 chain of type IV collagen // J. Clin. Invest. 1992; 89: 592–601.

  10. Hudson B.G., Tryggvason K., Sundaramoorthy M., Neilson E.G. Alport's syndrome, Goodpasture's syndrome, and type IV collagen // New Eng. J. Med. 2003; 348: 2543–2556.

  11. Pedchenko V., Bondar O., Fogo A.B., Vanacore R., Voziyan P., Kitching R., Wieslander J., Kashtan C., Borza D.-B., Neilson E.G., Wilson C.B., Hudson B.G. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis // New Eng. J. Med. 2010; 363: 343–354.

  12. Zhao J., Cui Z., Yang R., Jia X.Y., Zhang Y., Zhao M.H. Anti-glomerular basement membrane autoantibodies against different target antigens are associated with disease severity // Kidney Int. Nov 2009;76(10):1108–15.

  13. Donaghy M., Rees A.J. Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane // Lancet. Dec 17 1983;2 (8364):1390–3.

  14. Goodpasture syndrome. http://emedicine.medscape.com/article/240556-overview.

  15. Phelps R.G., Jones V., Turner A.N., Rees A.J. Properties of HLA class II molecules divergently associated with Goodpasture's disease // Int Immunol 2000 Aug;12(8):1135–1143.
  16. Salama A.D., Levy J.B., Lightstone C., Pusey C.D. Goodpasture?s disease // Lancet 2001; 358: 917–920.

  17. Levy J.B., Turner A.N., Rees A.J., Pusey C.D. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression // Ann Intern Med. Jun 5 2001;134(11):1033–42.

  18. Rossert J. Goodpasture’s disease. Orphanet encyclopedia. http://www.orpha.net/data/med/patho/GB/UK-goodpasture.pdf.

  19. Laczika K., Knapp S., Derfler K et al. Immunoadsorption in Goodpasture syndrome // Am.J Kidney Dis 2000; 36:392–425.

  20. Williamson S.R., Phillips C.L., Andreoli S.P., Nailescu C. A 25-year experience with pediatric anti-glomerular basement membrane disease // Pediatr Nephrol. 2011 Jan;26(1):85–91.

  21. Isselbacher K.J., Braunwald E., Wilson J.D., et al: Harrison's principles of internal medicine. ed 13; p1309. New York, 1994, McGraw-Hill.